Improving Access to Eye Care in Glaucoma Patients

Glaucoma Clinical Trial

Official title:

Improving Access to Eye Care in Glaucoma Patients a Prospective, Controlled, Randomized Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02982629
• Other study ID #: 410005727
• Status: Completed
• Phase: N/A
• Start date: March 2013
• Est. completion date: November 2013

Study information

• Verified date: December 2023
• Source: Wills Eye
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

1. To design and develop a prospective, randomized pilot study utilizing information from electronic medical records to address follow-up adherence and reduce the gap between recommended and actual follow-up adherence in patients with glaucoma.

2. To evaluate the impact of a telephone-based intervention on follow-up adherence in patients with glaucoma using a randomly assigned comparison with usual care.

Description:

The Wills Eye Health System (WEHS) proposes to conduct a pilot study to evaluate the feasibility and effectiveness of a telephone-based intervention to improve rates of follow-up exams in patients with glaucoma. The prospective, randomized, controlled trial entitled "Improving Access to Eye Care in Patients with Glaucoma" will utilize cohort data from 2013 electronic medical record information to reduce the gap between recommended and actual follow-up utilization of eye care services in glaucoma patients. Patients with glaucoma will be recruited from the Wills Eye Glaucoma clinic who were seen between 3/1/13 and 10/31/13. A recall list will be generated for patients who have scheduled follow-up appointments from 9/1/13 to 11/30/13. These patients will be randomly assigned to the "Usual Care" group or "Intervention" group. The primary outcome will be successful attendance at a follow-up appointment within an appropriate time frame. This intervention is based on a CDC funded project at Wills to improve access to eye care in patients with diabetes. Thus, this pilot study will test the efficacy of a telephone-based intervention to improve follow-up adherence in patients with glaucoma by improving access to eye care.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 250
• Est. completion date: November 2013
• Est. primary completion date: November 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 21 Years and older

Eligibility

Inclusion Criteria:

• Attended Wills Eye Glaucoma Clinic from 9/1/12 and 10/31/13

Exclusion Criteria:

• Any medical condition that would preclude the subject from providing reliable and valid data.

• Recommended to f/u in less than 1 month time period.

Related Conditions & MeSH terms

• Glaucoma

Intervention

Behavioral:
• Reminder letter Intervention
Patients in this group receive letters and phone calls to reschedule missed follow-up appointments.

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Wills Eye	Thomas Jefferson University

References & Publications (1)

Hark LA, Johnson DM, Berardi G, Patel NS, Zeng L, Dai Y, Mayro EL, Waisbourd M, Katz LJ. A randomized, controlled trial to test the effectiveness of a glaucoma patient navigator to improve appointment adherence. Patient Prefer Adherence. 2016 Sep 8;10:1739-48. doi: 10.2147/PPA.S108391. eCollection 2016. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Adherence to Follow-Up	Whether patients adhere to follow-up appointments at 28 weeks.	28 weeks